Valora Therapeutics
La Jolla, US · Founded 2023 · 19 employees on LinkedIn · 2 known investors
Find your way into Valora Therapeutics
41 people in our graph share verified history with the Valora Therapeutics team — schools, employers, funds. One of them is your warm intro.
Michael Kalosunlockedknows James Lee · together at University of Pennsylvania School of Medicine (overlapped)
×4knows the team · via Boundless Bio
×7knows the team · via University of Pennsylvania School of Medicine
Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
Founders & leadership
Valora Therapeutics was founded in 2023 by Miguel Garcia-Guzman, Carolyn Bertozzi, and Jessica Stark.
MG
CB
Carolyn BertozziScientific Co-Founder
JS
Jessica StarkinScientific Co-Founder
JL
James LeeinVP, Business DevelopmentJames Lee has over 15 years of experience in biotech and pharmaceutical business development and R&D across oncology and other therapeutic areas. He holds a bachelor's degree in bioengineering and a master's degree in molecular biotechnology from the University of Pennsylvania, and an MBA from Columbia Business School.
Board
SH
Stefan HellerBoard director
SM
Investors · 2
Reported raises · per SEC filings
Form D private placements$13M disclosed across 1 round · 2024
▶$13MraisedJul 2024 · 12 investors · BiotechnologyRule 506(b)
▶$13MraisedJul 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel Garcia-GuzmanExecutive Officer, Director
- Stefan HellerDirector
- Sanford MadiganDirector
- Offering amount
- $29.2M
- Amount sold
- $13M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Valora Therapeutics do?
- Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
- Who founded Valora Therapeutics?
- Valora Therapeutics was founded by Miguel Garcia-Guzman, Carolyn Bertozzi, Jessica Stark in 2023.
- Who are Valora Therapeutics's investors?
- Valora Therapeutics's investors include Avalon BioVentures, Correlation Ventures.
- How much funding has Valora Therapeutics raised?
- Valora Therapeutics has disclosed $13M raised across 1 round.
- Where is Valora Therapeutics headquartered?
- Valora Therapeutics is headquartered in La Jolla, US.